Search
Now showing items 1-4 of 4
Factors influencing the acceptance of directly observed therapy in the delivery of anti-retroviral drugs for treatment of Human Immunodeficiency Virus in Urban Uganda
(2008-05)
Background: Directly observed therapy for highly active antiretroviral therapy (DOT-HAART) has the potential to improve adherence and social support in HIV+ patients. Aims were to determine; the level of DOT-HAART acceptance, ...
HIV immune reconstitution syndrome in sub-Saharan Africa
(Lippincott Williams & Wilkins, 2008)
Over the last 5 years, there has been remarkable progress
in providing HAART to patients in developing countries.
In sub-Saharan Africa alone, the number receiving antiretroviral
therapy (ART) has more than doubled in ...
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy
(CID, 2008)
Background. Cryptococcal meningitis (CM) is the proximate cause of death in 20%–30% of persons with acquired immunodeficiency syndrome in Africa. Methods. Two prospective, observational cohorts enrolled human immunodeficiency ...
Biomarkers of HIV immune reconstitution inflammatory syndrome
(Future Medicine, 2008)
Dysregulation of the immune system drives HIV pathogenesis. As we develop new ways to treat HIV and AIDS, we encounter new clinical ramifications of our treatment on regulatory components of the Immune system. HIV-associated ...